Public trial registry of the CCC-Munich

Trial Abemacare

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Abemacare
World
Full title
:

Abemaciclib in Combination with Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients with Sy

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- Breastcancer
Trial design
World
Phase
:
nicht interventionell
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2020-11-03
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Hormon,Zielgerichtet - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Johannes Ettl Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Magnifier